NCT00246181View on ClinicalTrials.gov

Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Non-small Cell Lung Cancer
Interventions
PROCEDURE

radiation therapy

Patients will receive 3 fractions

Trial Locations (1)

46202

Indiana University, Department of Radiation Oncology, Indianapolis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jill Deluca

OTHER

NCT00246181 - Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC | Biotech Hunter | Biotech Hunter